Loading…
A method for murine islet isolation and subcapsular kidney transplantation
Since the early pioneering work of Ballinger and Reckard demonstrating that transplantation of islets of Langerhans into diabetic rodents could normalize their blood glucose levels, islet transplantation has been proposed to be a potential treatment for type 1 diabetes. More recently, advances in hu...
Saved in:
Published in: | Journal of visualized experiments 2011-04 (50) |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c513t-a6261e69b64c0c56459248bc40ad7980b07611e4f6768b59acf20dc7066a64483 |
---|---|
cites | |
container_end_page | |
container_issue | 50 |
container_start_page | |
container_title | Journal of visualized experiments |
container_volume | |
creator | Zmuda, Erik J Powell, Catherine A Hai, Tsonwin |
description | Since the early pioneering work of Ballinger and Reckard demonstrating that transplantation of islets of Langerhans into diabetic rodents could normalize their blood glucose levels, islet transplantation has been proposed to be a potential treatment for type 1 diabetes. More recently, advances in human islet transplantation have further strengthened this view. However, two major limitations prevent islet transplantation from being a widespread clinical reality: (a) the requirement for large numbers of islets per patient, which severely reduces the number of potential recipients, and (b) the need for heavy immunosuppression, which significantly affects the pediatric population of patients due to their vulnerability to long-term immunosuppression. Strategies that can overcome these limitations have the potential to enhance the therapeutic utility of islet transplantation. Islet transplantation under the mouse kidney capsule is a widely accepted model to investigate various strategies to improve islet transplantation. This experiment requires the isolation of high quality islets and implantation of islets to the diabetic recipients. Both procedures require surgical steps that can be better demonstrated by video than by text. Here, we document the detailed steps for these procedures by both video and written protocol. We also briefly discuss different transplantation models: syngeneic, allogeneic, syngeneic autoimmune, and allogeneic autoimmune. |
doi_str_mv | 10.3791/2096 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3169267</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>864191874</sourcerecordid><originalsourceid>FETCH-LOGICAL-c513t-a6261e69b64c0c56459248bc40ad7980b07611e4f6768b59acf20dc7066a64483</originalsourceid><addsrcrecordid>eNpVkE1LAzEQhoMotrb-BclB8LSaZLP5uAil-EnBi4K3kM1mbXQ3qcmu0H_v1mqpl5mBeXjnnReAKUaXOZf4iiDJDsAYS4oyJPjr4d48AicpvSPECCrEMRgRXJBC5GIMHmewtd0yVLAOEbZ9dN5ClxrbDTU0unPBQ-0rmPrS6FXqGx3hh6u8XcMuap9WjfbdDzYFR7Vukj397RPwcnvzPL_PFk93D_PZIjMFzrtMM8KwZbJk1CBTMFpIQkVpKNIVlwKViDOMLa0ZZ6IspDY1QZXhiDHNKBX5BFxvdVd92drKWD8YadQqulbHtQraqf8b75bqLXypHDNJGB8ELn4FYvjsbepU65KxzfCJDX1SglEsseB0IM-3pIkhpWjr3RWM1CZ1tUl9wM72He2gv5jzbyTbfQY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>864191874</pqid></control><display><type>article</type><title>A method for murine islet isolation and subcapsular kidney transplantation</title><source>PubMed Central</source><creator>Zmuda, Erik J ; Powell, Catherine A ; Hai, Tsonwin</creator><creatorcontrib>Zmuda, Erik J ; Powell, Catherine A ; Hai, Tsonwin</creatorcontrib><description>Since the early pioneering work of Ballinger and Reckard demonstrating that transplantation of islets of Langerhans into diabetic rodents could normalize their blood glucose levels, islet transplantation has been proposed to be a potential treatment for type 1 diabetes. More recently, advances in human islet transplantation have further strengthened this view. However, two major limitations prevent islet transplantation from being a widespread clinical reality: (a) the requirement for large numbers of islets per patient, which severely reduces the number of potential recipients, and (b) the need for heavy immunosuppression, which significantly affects the pediatric population of patients due to their vulnerability to long-term immunosuppression. Strategies that can overcome these limitations have the potential to enhance the therapeutic utility of islet transplantation. Islet transplantation under the mouse kidney capsule is a widely accepted model to investigate various strategies to improve islet transplantation. This experiment requires the isolation of high quality islets and implantation of islets to the diabetic recipients. Both procedures require surgical steps that can be better demonstrated by video than by text. Here, we document the detailed steps for these procedures by both video and written protocol. We also briefly discuss different transplantation models: syngeneic, allogeneic, syngeneic autoimmune, and allogeneic autoimmune.</description><identifier>ISSN: 1940-087X</identifier><identifier>EISSN: 1940-087X</identifier><identifier>DOI: 10.3791/2096</identifier><identifier>PMID: 21525838</identifier><language>eng</language><publisher>United States: MyJove Corporation</publisher><subject>Animals ; Islets of Langerhans - cytology ; Islets of Langerhans Transplantation - methods ; Kidney - surgery ; Medicine ; Mice ; Portal System - surgery</subject><ispartof>Journal of visualized experiments, 2011-04 (50)</ispartof><rights>Copyright © 2011, Journal of Visualized Experiments 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c513t-a6261e69b64c0c56459248bc40ad7980b07611e4f6768b59acf20dc7066a64483</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169267/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169267/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21525838$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zmuda, Erik J</creatorcontrib><creatorcontrib>Powell, Catherine A</creatorcontrib><creatorcontrib>Hai, Tsonwin</creatorcontrib><title>A method for murine islet isolation and subcapsular kidney transplantation</title><title>Journal of visualized experiments</title><addtitle>J Vis Exp</addtitle><description>Since the early pioneering work of Ballinger and Reckard demonstrating that transplantation of islets of Langerhans into diabetic rodents could normalize their blood glucose levels, islet transplantation has been proposed to be a potential treatment for type 1 diabetes. More recently, advances in human islet transplantation have further strengthened this view. However, two major limitations prevent islet transplantation from being a widespread clinical reality: (a) the requirement for large numbers of islets per patient, which severely reduces the number of potential recipients, and (b) the need for heavy immunosuppression, which significantly affects the pediatric population of patients due to their vulnerability to long-term immunosuppression. Strategies that can overcome these limitations have the potential to enhance the therapeutic utility of islet transplantation. Islet transplantation under the mouse kidney capsule is a widely accepted model to investigate various strategies to improve islet transplantation. This experiment requires the isolation of high quality islets and implantation of islets to the diabetic recipients. Both procedures require surgical steps that can be better demonstrated by video than by text. Here, we document the detailed steps for these procedures by both video and written protocol. We also briefly discuss different transplantation models: syngeneic, allogeneic, syngeneic autoimmune, and allogeneic autoimmune.</description><subject>Animals</subject><subject>Islets of Langerhans - cytology</subject><subject>Islets of Langerhans Transplantation - methods</subject><subject>Kidney - surgery</subject><subject>Medicine</subject><subject>Mice</subject><subject>Portal System - surgery</subject><issn>1940-087X</issn><issn>1940-087X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNpVkE1LAzEQhoMotrb-BclB8LSaZLP5uAil-EnBi4K3kM1mbXQ3qcmu0H_v1mqpl5mBeXjnnReAKUaXOZf4iiDJDsAYS4oyJPjr4d48AicpvSPECCrEMRgRXJBC5GIMHmewtd0yVLAOEbZ9dN5ClxrbDTU0unPBQ-0rmPrS6FXqGx3hh6u8XcMuap9WjfbdDzYFR7Vukj397RPwcnvzPL_PFk93D_PZIjMFzrtMM8KwZbJk1CBTMFpIQkVpKNIVlwKViDOMLa0ZZ6IspDY1QZXhiDHNKBX5BFxvdVd92drKWD8YadQqulbHtQraqf8b75bqLXypHDNJGB8ELn4FYvjsbepU65KxzfCJDX1SglEsseB0IM-3pIkhpWjr3RWM1CZ1tUl9wM72He2gv5jzbyTbfQY</recordid><startdate>20110413</startdate><enddate>20110413</enddate><creator>Zmuda, Erik J</creator><creator>Powell, Catherine A</creator><creator>Hai, Tsonwin</creator><general>MyJove Corporation</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20110413</creationdate><title>A method for murine islet isolation and subcapsular kidney transplantation</title><author>Zmuda, Erik J ; Powell, Catherine A ; Hai, Tsonwin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c513t-a6261e69b64c0c56459248bc40ad7980b07611e4f6768b59acf20dc7066a64483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Animals</topic><topic>Islets of Langerhans - cytology</topic><topic>Islets of Langerhans Transplantation - methods</topic><topic>Kidney - surgery</topic><topic>Medicine</topic><topic>Mice</topic><topic>Portal System - surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zmuda, Erik J</creatorcontrib><creatorcontrib>Powell, Catherine A</creatorcontrib><creatorcontrib>Hai, Tsonwin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of visualized experiments</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zmuda, Erik J</au><au>Powell, Catherine A</au><au>Hai, Tsonwin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A method for murine islet isolation and subcapsular kidney transplantation</atitle><jtitle>Journal of visualized experiments</jtitle><addtitle>J Vis Exp</addtitle><date>2011-04-13</date><risdate>2011</risdate><issue>50</issue><issn>1940-087X</issn><eissn>1940-087X</eissn><abstract>Since the early pioneering work of Ballinger and Reckard demonstrating that transplantation of islets of Langerhans into diabetic rodents could normalize their blood glucose levels, islet transplantation has been proposed to be a potential treatment for type 1 diabetes. More recently, advances in human islet transplantation have further strengthened this view. However, two major limitations prevent islet transplantation from being a widespread clinical reality: (a) the requirement for large numbers of islets per patient, which severely reduces the number of potential recipients, and (b) the need for heavy immunosuppression, which significantly affects the pediatric population of patients due to their vulnerability to long-term immunosuppression. Strategies that can overcome these limitations have the potential to enhance the therapeutic utility of islet transplantation. Islet transplantation under the mouse kidney capsule is a widely accepted model to investigate various strategies to improve islet transplantation. This experiment requires the isolation of high quality islets and implantation of islets to the diabetic recipients. Both procedures require surgical steps that can be better demonstrated by video than by text. Here, we document the detailed steps for these procedures by both video and written protocol. We also briefly discuss different transplantation models: syngeneic, allogeneic, syngeneic autoimmune, and allogeneic autoimmune.</abstract><cop>United States</cop><pub>MyJove Corporation</pub><pmid>21525838</pmid><doi>10.3791/2096</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1940-087X |
ispartof | Journal of visualized experiments, 2011-04 (50) |
issn | 1940-087X 1940-087X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3169267 |
source | PubMed Central |
subjects | Animals Islets of Langerhans - cytology Islets of Langerhans Transplantation - methods Kidney - surgery Medicine Mice Portal System - surgery |
title | A method for murine islet isolation and subcapsular kidney transplantation |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T22%3A49%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20method%20for%20murine%20islet%20isolation%20and%20subcapsular%20kidney%20transplantation&rft.jtitle=Journal%20of%20visualized%20experiments&rft.au=Zmuda,%20Erik%20J&rft.date=2011-04-13&rft.issue=50&rft.issn=1940-087X&rft.eissn=1940-087X&rft_id=info:doi/10.3791/2096&rft_dat=%3Cproquest_pubme%3E864191874%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c513t-a6261e69b64c0c56459248bc40ad7980b07611e4f6768b59acf20dc7066a64483%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=864191874&rft_id=info:pmid/21525838&rfr_iscdi=true |